Solute carrier family 25 member 14 pseudogene 1 (SLC25A14P1)

Solute carrier family 25 member 14 pseudogene 1 (SLC25A14P1) is annotated as a pseudogene derived from the SLC25A14 gene, which encodes a mitochondrial carrier protein predominantly expressed in the brain[1][5][6][7]. Pseudogenes are generally defined as genomic DNA sequences similar to normal genes but nonfunctional; most do not encode a functional protein due to disabling mutations or lack of necessary regulatory elements[2]. While SLC25A14P1 does not produce protein, research suggests that some pseudogenes may still play regulatory roles, such as acting as sources of noncoding RNA or as decoys for microRNAs, thereby indirectly affecting gene expression and possibly influencing complex diseases, such as cancer[2][4]. SLC25A14P1 itself has been referenced in the context of disease-associated pseudogene profiling, but no direct functional, biomarker, or pharmacological data exist for it specifically[3][4]. Overall, this entity is not a conventional therapeutic target such as a receptor, transporter, or enzyme, and thus lacks clinical drug interactions, mechanisms of action, established biomarkers, or drug safety profiles. The "pseudogene" designation indicates that its principal relevance is for genomics, gene regulation research, or as part of disease association studies rather than as a druggable target[2][4]. - Important technical note: This entry is not a true therapeutic target. Its inclusion in target/biomarker lists may be inappropriate unless specifically seeking regulatory noncoding RNA involvement[1][2][4].

Other names

Solute carrier family 25 (mitochondrial carrier, brain), member 14 pseudogene 1